Cargando…

Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics

Therapeutic hypothermia (TH) is the only intervention approved for the treatment of neonatal hypoxic-ischaemic encephalopathy (HIE), but its treatment window is narrow (within 6 h after birth), and its efficacy is not ideal. Thus, alternative treatments are urgently needed. Our previous studies show...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ting, Shuang, Liyan, Liu, Gaigai, Zhao, Shanshan, Yuan, Zhidong, Cai, Hao, Jiang, Lixia, Huang, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849302/
https://www.ncbi.nlm.nih.gov/pubmed/36370154
http://dx.doi.org/10.1007/s12035-022-03123-8
_version_ 1784871923586433024
author Xie, Ting
Shuang, Liyan
Liu, Gaigai
Zhao, Shanshan
Yuan, Zhidong
Cai, Hao
Jiang, Lixia
Huang, Zhihua
author_facet Xie, Ting
Shuang, Liyan
Liu, Gaigai
Zhao, Shanshan
Yuan, Zhidong
Cai, Hao
Jiang, Lixia
Huang, Zhihua
author_sort Xie, Ting
collection PubMed
description Therapeutic hypothermia (TH) is the only intervention approved for the treatment of neonatal hypoxic-ischaemic encephalopathy (HIE), but its treatment window is narrow (within 6 h after birth), and its efficacy is not ideal. Thus, alternative treatments are urgently needed. Our previous studies showed that genistein-3′-sodium sulfonate (GSS), a derivative of genistein (Gen), has a strong neuroprotective effect in rats with ischaemic stroke, but its role in HIE is unclear. A hypoxia–ischaemia (HI) brain injury model was established in neonatal male Sprague‒Dawley (SD) rats. Twenty-four hours after reperfusion, rats treated with GSS were assessed for cerebral infarction, neurological function, and neuronal damage. RNA-Seq and bioinformatics analysis were used to explore differentially expressed genes (DEGs) and regulated signalling pathways, which were subsequently validated by Western blotting and immunofluorescence. In this study, we found that GSS not only significantly reduced the size of brain infarcts and alleviated nerve damage in rats with HIE but also inhibited neuronal loss and degeneration in neonatal rats with HIE. A total of 2170 DEGs, of which 1102 were upregulated and 1068 were downregulated, were identified in the GSS group compared with the HI group. In an analysis based on Kyoto Encyclopedia of Genes and Genomes (KEGG) categories, the downregulated DEGs were significantly enriched in the pathways “Phagosome”, “NF-κB signalling”, and “Complement and coagulation cascades”, amongst others. Meanwhile, the upregulated DEGs were significantly enriched in the pathways “Neurodegeneration”, “Glutamatergic synapse”, and “Calcium signalling pathway”, amongst others. These results indicate that GSS intervenes in the process of HIE-induced brain injury by participating in multiple pathways, which suggests potential candidate drugs for the treatment of HIE. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9849302
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-98493022023-01-20 Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics Xie, Ting Shuang, Liyan Liu, Gaigai Zhao, Shanshan Yuan, Zhidong Cai, Hao Jiang, Lixia Huang, Zhihua Mol Neurobiol Article Therapeutic hypothermia (TH) is the only intervention approved for the treatment of neonatal hypoxic-ischaemic encephalopathy (HIE), but its treatment window is narrow (within 6 h after birth), and its efficacy is not ideal. Thus, alternative treatments are urgently needed. Our previous studies showed that genistein-3′-sodium sulfonate (GSS), a derivative of genistein (Gen), has a strong neuroprotective effect in rats with ischaemic stroke, but its role in HIE is unclear. A hypoxia–ischaemia (HI) brain injury model was established in neonatal male Sprague‒Dawley (SD) rats. Twenty-four hours after reperfusion, rats treated with GSS were assessed for cerebral infarction, neurological function, and neuronal damage. RNA-Seq and bioinformatics analysis were used to explore differentially expressed genes (DEGs) and regulated signalling pathways, which were subsequently validated by Western blotting and immunofluorescence. In this study, we found that GSS not only significantly reduced the size of brain infarcts and alleviated nerve damage in rats with HIE but also inhibited neuronal loss and degeneration in neonatal rats with HIE. A total of 2170 DEGs, of which 1102 were upregulated and 1068 were downregulated, were identified in the GSS group compared with the HI group. In an analysis based on Kyoto Encyclopedia of Genes and Genomes (KEGG) categories, the downregulated DEGs were significantly enriched in the pathways “Phagosome”, “NF-κB signalling”, and “Complement and coagulation cascades”, amongst others. Meanwhile, the upregulated DEGs were significantly enriched in the pathways “Neurodegeneration”, “Glutamatergic synapse”, and “Calcium signalling pathway”, amongst others. These results indicate that GSS intervenes in the process of HIE-induced brain injury by participating in multiple pathways, which suggests potential candidate drugs for the treatment of HIE. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2022-11-12 2023 /pmc/articles/PMC9849302/ /pubmed/36370154 http://dx.doi.org/10.1007/s12035-022-03123-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Xie, Ting
Shuang, Liyan
Liu, Gaigai
Zhao, Shanshan
Yuan, Zhidong
Cai, Hao
Jiang, Lixia
Huang, Zhihua
Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics
title Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics
title_full Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics
title_fullStr Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics
title_full_unstemmed Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics
title_short Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics
title_sort insight into the neuroprotective effect of genistein-3′-sodium sulfonate against neonatal hypoxic-ischaemic brain injury in rats by bioinformatics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849302/
https://www.ncbi.nlm.nih.gov/pubmed/36370154
http://dx.doi.org/10.1007/s12035-022-03123-8
work_keys_str_mv AT xieting insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics
AT shuangliyan insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics
AT liugaigai insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics
AT zhaoshanshan insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics
AT yuanzhidong insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics
AT caihao insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics
AT jianglixia insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics
AT huangzhihua insightintotheneuroprotectiveeffectofgenistein3sodiumsulfonateagainstneonatalhypoxicischaemicbraininjuryinratsbybioinformatics